N7. Have you looked at AMRN's long term inventory ..it's in their 10Q . At some point they have to dump that on the market ...or write it off . They may have used that ( a good idea ) in a special deal , to under cut the generics for the CVS contract Good luck Kiwi
This puts $12 million back in our pockets each quarter, likely eliminating the losses that caused us to lose about 8 percent of our cash on hand in the last year and it should restore the long runway the company needs to fully launch its lone drug across the planet. It also makes us a much more appealing buyout target.
Market Data 
Markets 
AI
